ÂÜÀòÂÒÂ×

Dalia Rivenzon-Segal is a Partner and Patent Attorney at Reinhold Cohn Group, with over a decade of experience specializing in Intellectual Property matters related to pharmaceuticals, medicinal chemistry, computational chemistry, imaging techniques, cell biology, bioinformatics, biochemistry, and medical devices. Since joining Reinhold Cohn Group in 2010, Dalia has been actively involved in drafting and prosecuting patent applications, handling litigation in Israel and abroad, providing legal opinions on patentability and Freedom-to-Operate, and conducting IP Due Diligence processes. Prior experience includes serving as a Senior Scientist in Computational Chemistry at EPIX Pharmaceuticals from 2006 to 2009, a Postdoctoral Fellow, and a Ph.D. student at the Weizmann Institute of Science. Dalia earned a PhD from the Weizmann Institute of Science from 1995 to 2001 and holds degrees from The Hebrew University of Jerusalem, attained between 1991 and 1994.